The global Gliclazide market was valued at US$ 450 million in 2022 and is projected to reach US$ 650 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period (2022–2030). This growth is being driven by the rising prevalence of type 2 diabetes worldwide, increasing demand for oral hypoglycemic agents, and the expanding focus on affordable generic medications in emerging markets. Factors such as aging populations, lifestyle changes, and advancements in sulfonylurea formulations are further propelling the market forward.

As the pharmaceutical sector evolves to address the global diabetes epidemic with more effective and accessible treatments, the spotlight is on the key manufacturers and suppliers who are driving innovation, quality, and reliable supply chains. In this blog, we profile the Top 10 Companies in the Gliclazide Market—a blend of fine chemicals specialists, pharmaceutical producers, and global distributors shaping the future of diabetes care.

---

🔟 1. Discovery Fine Chemicals

Headquarters: Wimborne, Dorset, United Kingdom
Key Offering: High-purity Gliclazide API (Min Purity >99%), custom synthesis services

Discovery Fine Chemicals stands out as a premier UK-based supplier of pharmaceutical intermediates and APIs, with a strong emphasis on Gliclazide production for both research and commercial applications. The company caters to global pharmaceutical firms by providing consistent, high-quality gliclazide that meets stringent regulatory requirements from agencies like the FDA and EMA. Their expertise in scalable synthesis ensures reliable supply for diabetes drug formulations, helping manufacturers meet growing demand in Europe and beyond.

Innovation Initiatives:

• Advanced chromatographic purification techniques for ultra-high purity APIs

• Collaborations with research institutions on modified-release gliclazide variants

• Commitment to sustainable manufacturing practices, reducing solvent use by 20% in recent processes

Download FREE Sample Report: Gliclazide Market – View in Detailed Research Report

---

9️⃣ 2. Carbomer Inc.

Headquarters: San Diego, California, USA
Key Offering: Gliclazide API (Min Purity 98-99%), excipient-integrated formulations

Carbomer Inc. is a key player in the U.S. fine chemicals sector, specializing in sulfonylurea compounds like gliclazide for pharmaceutical and research uses. Operating with a focus on North American and European markets, the company supplies gliclazide to generic drug producers, emphasizing batch consistency and compliance with cGMP standards. Their role in the supply chain supports the development of cost-effective diabetes treatments, particularly as generics gain traction amid rising healthcare costs.

Innovation Initiatives:

• Investment in green chemistry for eco-friendly API synthesis

• Partnerships with contract manufacturers to optimize gliclazide tablet production

---

8️⃣ 3. HBCChem, Inc.

Headquarters: Hayward, California, USA
Key Offering: Gliclazide reference standards (Min Purity <98% for lab use), bulk chemicals

HBCChem serves as an essential supplier of gliclazide for laboratory and early-stage pharmaceutical development, with a robust presence in the American research market. The company provides various purity grades to support analytical testing and formulation trials, contributing to advancements in diabetes pharmacotherapy. By maintaining short lead times and competitive pricing, HBCChem helps accelerate R&D efforts for new gliclazide-based therapies.

Innovation Initiatives:

• Development of analytical kits for gliclazide purity assessment

• Expansion into biotech collaborations for novel sulfonylurea derivatives

---

7️⃣ 4. Ivy Fine Chemicals

Headquarters: Branford, Connecticut, USA
Key Offering: Custom Gliclazide synthesis (Min Purity >99%), pharmaceutical intermediates

Ivy Fine Chemicals excels in bespoke production of gliclazide and related compounds, serving multinational pharma companies with tailored solutions. Based in the U.S., they focus on high-end research and development applications, ensuring their products integrate seamlessly into clinical trials and commercial production lines. This approach has positioned them as a trusted partner in enhancing the efficacy and safety profiles of diabetes medications.

Innovation Initiatives:

• Goal to achieve 100% traceability in supply chains by 2025

• U.S.-based R&D center dedicated to sulfonylurea enhancements

Download FREE Sample Report: Gliclazide Market – View in Detailed Research Report

---

6️⃣ 5. Clearsynth

Headquarters: Hyderabad, India
Key Offering: Gliclazide API (Min Purity 98-99%), stable isotope-labeled versions

Clearsynth, an India-headquartered leader in fine chemicals, supplies gliclazide for global pharmaceutical applications, leveraging cost-effective production while upholding international quality norms. Their facilities produce large volumes for generic manufacturers, supporting accessible diabetes care in developing regions. The company’s growth mirrors the surge in generic drug demand, making them a cornerstone in the Asian export market.

Innovation Initiatives:

• Certified production of labeled gliclazide for pharmacokinetic studies

• Initiatives for process optimization to cut production costs by 15%

---

5️⃣ 6. Bal Pharma Limited

Headquarters: Bangalore, India
Key Offering: Formulated Gliclazide tablets, API (Min Purity >99%)

Bal Pharma is a prominent Indian pharmaceutical firm deeply involved in gliclazide production and formulation, targeting both domestic and international markets. With WHO-GMP certified plants, they deliver finished dosage forms that aid in effective glycemic control for millions. Their integrated approach from API to final product ensures quality and affordability, addressing the needs of emerging economies where diabetes rates are climbing rapidly.

Innovation Initiatives:

• Current output exceeds 500 tons annually for gliclazide APIs

• Target to launch extended-release formulations by 2026

---

4️⃣ 7. Fengchen Group

Headquarters: Qingdao, China
Key Offering: Bulk Gliclazide (Min Purity 98-99%), export-grade APIs

Fengchen Group, a major Chinese chemical exporter, plays a critical role in gliclazide supply to Asia-Pacific and global markets. Specializing in large-scale production, they provide economical solutions for pharmaceutical companies seeking high-volume, reliable sources. Despite geopolitical challenges, their focus on quality control has solidified their position in the international trade of diabetes-related APIs.

Innovation Initiatives:

• Ongoing R&D for cost-efficient synthesis methods

• Compliance with global pharmacopeia standards for export

---

3️⃣ 8. Sinopharm Group

Headquarters: Beijing, China
Key Offering: Gliclazide formulations and APIs (Min Purity >99%), healthcare distribution

Sinopharm, China’s largest pharmaceutical conglomerate, dominates the domestic gliclazide market while expanding internationally. Their vertically integrated operations cover production, distribution, and retail, ensuring widespread availability of gliclazide-based treatments. This scale enables them to influence pricing and accessibility, particularly in one of the world’s fastest-growing diabetes populations.

Innovation Initiatives:

• Indigenous research into combination therapies with gliclazide

• Government-backed programs to enhance production capacity

---

2️⃣ 9. Hairuichem

Headquarters: Dalian, China
Key Offering: Gliclazide API (Min Purity <98% for research), fine chemicals

Hairuichem specializes in research-grade gliclazide, supplying academic and industrial labs worldwide with versatile purity options. As a nimble Chinese manufacturer, they adapt quickly to market needs, supporting exploratory studies on sulfonylureas. Their contributions extend to early drug discovery, fostering innovations in diabetes management.

Innovation Initiatives:

• Aims to expand renewable sourcing for chemical intermediates

• Major investments in analytical technology upgrades

---

1️⃣ 10. Dayang Chem (Hangzhou Dayangchem Co., Ltd.)

Headquarters: Hangzhou, China
Key Offering: Comprehensive Gliclazide supply chain, APIs and intermediates (All purity grades)

Dayang Chem leads the Gliclazide market with end-to-end solutions, from raw materials to finished APIs, serving over 1,000 clients globally. Their extensive logistics network ensures timely delivery to pharmaceutical hubs in Asia, Europe, and the Americas. As a top exporter, they drive market growth through competitive pricing and unwavering quality, making gliclazide more accessible for diabetes treatment worldwide.

Innovation Initiatives:

• Full-spectrum solutions including custom API modifications

• Strategic alliances with pharma giants for sustained supply

Get Full Report Here: Gliclazide Market – View in Detailed Research Report

---

🌍 Outlook: The Future of the Gliclazide Market Is Innovative and Patient-Centric

The Gliclazide market is experiencing steady evolution, with traditional API production giving way to enhanced formulations and broader accessibility. As diabetes cases are projected to reach 700 million globally by 2045, the industry is channeling resources into generic expansions, combination therapies, and supply chain digitalization to meet escalating needs.

📈 Key Trends Shaping the Market:

• Expansion of generic production in Asia to lower costs for emerging markets

• Regulatory approvals for modified-release gliclazide variants by 2030

• Digital tracking in supply chains for better traceability and compliance

• Collaborations between manufacturers and healthcare providers for diabetes programs

Get Full Report Here: Gliclazide Market – View in Detailed Research Report

The companies highlighted here are not only supplying essential gliclazide—they’re pioneering the next era of diabetes care through innovation and global reach.